Comparison of OCT Angiography Parameters after Administration of Intravitreal Brolucizumab versus Ranibizumab in Exudative Age-related Macular Degeneration
Purpose: To compare the OCT angiography (OCTA)–derived parametric changes before and after intravitreal administration of ranibizumab and brolucizumab in patients with neovascular age-related macular degeneration (ARMD) and to compare the changes between the two groups. Methods: This retrospective c...
Saved in:
Main Authors: | Sanjitha Vilma Moses, Aadithreya Varman, Dinesh Balakumar, Arulmozhi Varman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | TNOA Journal of Ophthalmic Science and Research |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/tjosr.tjosr_61_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of neovascular age-related macular degeneration: one year real-life results with intravitreal Brolucizumab
by: Settimio Rossi, et al.
Published: (2025-01-01) -
Pooled Multicenter Safety Analysis of Lupin’s Intravitreal Biosimilar Ranibizumab (Ranieyes) in Chorioretinal Vascular Diseases
by: Debdulal Chakraborty, et al.
Published: (2024-11-01) -
Efficacy & safety of brolucizumab 6.0 mg versus 3.6 mg in diabetic macular edema
by: Sanjay Kumar Mishra, et al.
Published: (2025-01-01) -
Early OCT Angiography Changes of Macular Neovascularization in Patients with Exudative AMD Treated with Brolucizumab in a Real-World Setting
by: Anne Rübsam, et al.
Published: (2022-01-01) -
Innovator ranibizumab ComparEd to Biosimilar ranibizumab in combination with Expansile gas in submaculaR HemorrhaGe: the ICEBERG study
by: Debdulal Chakraborty, et al.
Published: (2025-01-01)